Wednesday, December 3, 2014

Rare disease biotech deal

Jean-Jacques Bienaime, BioMarin Pharma CEO, discusses the company' s Prosensa acquisition.

Video (7:09)

http://video.cnbc.com/gallery/?video=3000335935

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.